APP and autism: This data suggests that subsets of autistic patients have elevated brain levels of the sAPPα and α-CTF fragments of APP, signifying a greater inclination towards the non-amyloidogenic pathway in patient brains and a potential role for the associated fragments in the pathophysiology of autism.